Articles about Biotech – Page 6 of 8

Q&A: Cancer research leader Nancy Davidson on the innovations of the past decade, and where things are heading next

We often hear that medical research is approaching “breakthroughs” or is at a “tipping point” in innovation. But what does… Read More

Study: ID Genomics’ bacteria ‘fingerprinting’ technology helps doctors diagnose infection more accurately

The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it… Read More

No more needle and thread? This startup is developing a high-tech replacement for stitches

Whether they’re on a busted lip or helping close wounds after surgery, stitches and other sutures are a familiar presence… Read More

Study: Seattle-area startup’s test diagnoses heart disease more effectively than current methods

Prevencio, a Kirkland, Wash., based biotech startup, today announced the results of the first study on its HART test, which… Read More

Nativis raises $10M for device that uses electromagnetic fields to mimic the effects of cancer drugs

Imagine an external device that could have the same effect, when pointed at a tumor, as a cancer drug. It… Read More

Inside Nohla Therapeutics’ new Seattle biotech lab as Gov. Jay Inslee geeks out on science

It’s no secret that wet lab space is hard to come by in Seattle. Small biotech companies often struggle to… Read More

ID Genomics consortium to build national database of bacterial ‘fingerprints’ to help doctors diagnose infection

There’s a reason bacteria take up almost an entire kingdom in our map of life: they are an endlessly complex… Read More

Gates Foundation pledges up to $140M for HIV-fighting drug delivery implant

The Bill & Melinda Gates Foundation is committing up to $140 million to help Boston biotech company Intarcia Therapeutics develop… Read More

Fred Hutch spinout Nohla Therapeutics raises $43.5M to develop therapy for Leukemia

Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More

PhaseRx liver disease drug receives boost from FDA, stock soars

Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More

Heavily-funded Bay Area startup opening office in Seattle to fuel biological engineering

Zymergen, a biological engineering startup based in the San Francisco area, is building out an engineering center in Seattle, GeekWire… Read More

Electrodes on the brain could return sense of ‘touch feedback’ to patients with spinal cord injuries

In a study to be published this month, University of Washington researchers announce a promising discovery: electrodes placed on the… Read More

Seattle’s Sound Pharmaceuticals raising $30M to advance trials of hearing-loss drug

Sound Pharmaceuticals, a Seattle startup developing therapies and preventative treatments for hearing loss, is in the midst of a $30 million… Read More

Study of Juno Therapeutics cancer treatment shows high rates of remission, possible promise for other drugs

A study published today on a Juno Therapeutics immunotherapy treatment for blood cancers shows that the drug and others like it could… Read More

Fred Hutch study: Cord blood transplants may be more effective for high-risk Leukemia patients

When a patient is diagnosed with Leukemia or another blood cancer, they generally undergo long, painful rounds of chemotherapy to… Read More

Prevencio announces successful study of predictive blood tests for coronary heart disease

Prevencio, a Kirkland, Wash., based biotech startup, announced today a successful study on its suite of blood diagnostic tests. The… Read More

Biotech firm OncoGenex sees stock sink 40% after unsuccessful clinical trial

OncoGenex, a pharmaceutical firm based in Bothell, Wash., announced today an unsuccessful end to their phase 3 clinical trial of an… Read More

Podcast

GeekWire Radio: Olympics streaming tips, ReachNow at the Seattle airport, and more

This week on the GeekWire radio show and podcast: BMW’s ReachNow car sharing program added service to Seattle’s SeaTac Airport this week.… Read More

How biotech visionary Leroy Hood redefined the industry: Q&A with biographer Luke Timmerman

In the quest for a better understanding of the human body, the automated DNA sequencer was a breakthrough innovation, giving… Read More

Seattle biotech entrepreneur Ron Berenson raising cash for new startup

Ron Berenson has another biotechnology startup in the works, a new company by the name of DMD Therapeutics. The Seattle-based company recently… Read More

Sneak peek: New biography of biotech pioneer Leroy Hood is revealing and rigorously reported

“Mr. Gates, I Quit.” That’s the opening chapter of “Hood: Trailblazer of the Genomics Age,” and it’s just the first indication… Read More

Why biotech investments in Washington state have dropped to the lowest levels since 2011

Seattle’s biotechnology industry has never really taken root — undergoing a series of ups and downs as companies such as… Read More

Seattle just got another publicly traded biotech company

Seattle-based Aptevo Therapeutics completed a spinoff from Emergent BioSolutions Monday, making a debut in the public markets as a standalone company.… Read More

BioMed Realty opening new biotech startup space in lab-starved Seattle

Startup, co-working and incubator spaces are proliferating throughout the Puget Sound region. But Seattle isn’t just a tech town, it’s… Read More

Alpine Immune Sciences raises $48 million for cancer and autoimmune treatment

Seattle’s Alpine Immune Sciences says it has closed a $48 million Series A financing round, to fund the development of… Read More

Legacies that save lives: Washington Life Science Hall of Fame gets first members

Six medical pioneers were inducted into the newly created Washington Life Science Hall of Fame today, and although some of… Read More

Designer proteins, created and edited on computers, open up new biotech frontiers

Synthetic genomes and gene editing are big things today, but the next big things in biotechnology could be proteins that are… Read More

Cardiac Insight closes $2.5M funding round to identify heart problems in young athletes

Cardiac Insight is preparing for the launch of its CardeaScreen technology, and the company has raised $2.5 million to help spur… Read More

BioViva’s Liz Parrish makes progress in controversial gene quest to reverse aging

The way BioViva founder Elizabeth Parrish sees it, biological aging is a disease – and she’s willing to bet her life on a… Read More

Institute for Systems Biology joins Providence; Biotech pioneer Leroy Hood named health system’s chief science officer

The non-profit Institute for Systems Biology, a Seattle-based biomedical research organization that has spun off eight companies in the past 15 years, is joining Providence… Read More